752
Views
39
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEPreclinical Therapeutics

Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice

, , , , &
Pages 74-84 | Published online: 09 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Claudia Marchetti, Ludovico Muzii, Alessia Romito & Pierluigi Benedetti Panici. (2019) First-line treatment of women with advanced ovarian cancer: focus on bevacizumab. OncoTargets and Therapy 12, pages 1095-1103.
Read now
Roberto Filippi, Pasquale Lombardi, Ilaria Depetris, Elisabetta Fenocchio, Virginia Quarà, Giovanna Chilà, Massimo Aglietta & Francesco Leone. (2018) Rationale for the use of metronomic chemotherapy in gastrointestinal cancer. Expert Opinion on Pharmacotherapy 19:13, pages 1451-1463.
Read now

Articles from other publishers (37)

Gustavo Rosero, Gisela Pattarone, Ana Peñaherera, Julia Pilz, Joschka Bödecker, Maximiliano Perez, Roland Mertelsmann, Betiana Lerner & Marie Follo. (2022) Metronomic doses and drug schematic combination response tested within chambered coverslips for the treatment of breast cancer cells (JIMT-1). PLOS ONE 17:9, pages e0274911.
Crossref
Victoria Lai, Sarah Y. Neshat, Amanda Rakoski, James Pitingolo & Joshua C. Doloff. (2021) Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity. Advanced Drug Delivery Reviews 179, pages 113920.
Crossref
Linda Wordeman & Juan Jesus Vicente. (2021) Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles. Cancers 13:22, pages 5650.
Crossref
Minsik Park, Joohwan Kim, Taesam Kim, Suji Kim, Wonjin Park, Kwon-Soo Ha, Sung Hwan Cho, Moo-Ho Won, Jeong-Hyung Lee, Young-Guen Kwon & Young-Myeong Kim. (2021) REDD1 is a determinant of low-dose metronomic doxorubicin-elicited endothelial cell dysfunction through downregulation of VEGFR-2/3 expression. Experimental & Molecular Medicine 53:10, pages 1612-1622.
Crossref
Vincent A. de Weger, Marit A.C. Vermunt, Frederik E. Stuurman, Artur M. Burylo, David Damoiseaux, Jeroen J.M.A. Hendrikx, Emilia Sawicki, Johannes J. Moes, Alwin D.R. Huitema, Bastiaan Nuijen, Hilde Rosing, Marja Mergui‐Roelvink, Jos H. Beijnen & Serena Marchetti. (2020) A Phase 1 Dose‐Escalation Study of Low‐Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors. Clinical Pharmacology in Drug Development 10:6, pages 607-621.
Crossref
Zhong‐Sheng Xiao, Lei Zhao, Xiao‐Ning Zhang, Han‐Xian Li & Zhi‐Hui Yin. (2021) Effect of rs67085638 in long non‐coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA‐24‐3p and FSCN1. Journal of Cellular and Molecular Medicine 25:8, pages 3744-3753.
Crossref
Ji‐In Yang, Bohwan Jin, Su‐Yeon Kim, Qiang Li, Aryung Nam, Min‐Ok Ryu, Won Woo Lee, Min‐Hee Son, Hye‐Jin Park, Woo‐Jin Song & Hwa‐Young Youn. (2019) Antitumour effects of Liporaxel (oral paclitaxel) for canine melanoma in a mouse xenograft model. Veterinary and Comparative Oncology 18:2, pages 152-160.
Crossref
O. Graciela Scharovsky, María José Rico, Leandro E. Mainetti, Herman A. Perroud & Viviana R. Rozados. (2020) Achievements and challenges in the use of metronomics for the treatment of breast cancer. Biochemical Pharmacology 175, pages 113909.
Crossref
Anusha Pusuluri, Debra Wu & Samir Mitragotri. (2019) Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments. Journal of Controlled Release 305, pages 130-154.
Crossref
Marina Santiago Franco, Marjorie Coimbra Roque, André Luís Branco de Barros, Juliana de Oliveira Silva, Geovanni Dantas Cassali & Mônica Cristina Oliveira. (2019) Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model. Biomedicine & Pharmacotherapy 109, pages 1728-1739.
Crossref
Luisa Ruiz-Gatón, Socorro Espuelas, Eneko Larrañeta, Ilya Reviakine, Luis A. Yate & Juan M. Irache. (2018) Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel. European Journal of Pharmaceutical Sciences 118, pages 165-175.
Crossref
Mu Zhang, Chen Chen, Feng Su, Zhiguo Huang, Xiangmin Li & Xiaogang Li. (2016) Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts. Technology in Cancer Research & Treatment 16:5, pages 609-619.
Crossref
Yu-Li Chen, Ming-Cheng Chang & Wen-Fang Cheng. (2017) Metronomic chemotherapy and immunotherapy in cancer treatment. Cancer Letters 400, pages 282-292.
Crossref
Chaoxiang Lv, Hao Qu, Wanyun Zhu, Kaixiang Xu, Anyong Xu, Baoyu Jia, Yubo Qing, Honghui Li, Hong-Jiang Wei & Hong-Ye Zhao. (2017) Low-Dose Paclitaxel Inhibits Tumor Cell Growth by Regulating Glutaminolysis in Colorectal Carcinoma Cells. Frontiers in Pharmacology 8.
Crossref
Shih-Hsin Tu, Yi-Shiou Chiou, Nagabhushanam Kalyanam, Chi-Tang Ho, Li-Ching Chen & Min-Hsiung Pan. (2017) Garcinol sensitizes breast cancer cells to Taxol through the suppression of caspase-3/iPLA 2 and NF-κB/Twist1 signaling pathways in a mouse 4T1 breast tumor model . Food & Function 8:3, pages 1067-1079.
Crossref
Stéphane Vignot, Thierry André, Anthony Gonçalves, Romain Guièze, Nicolas Magné, Daniel Orbach, Nicolas Penel, Juliette Thariat, Marie Wislez & Jacques-Olivier Bay. (2017) Quels résultats de l’année 2016 vont avoir un impact sur nos pratiques ? Le point de vue du Comité de rédaction du Bulletin du Cancer. Bulletin du Cancer 104:1, pages 6-19.
Crossref
Anna-Maria Olziersky & S. Intidhar Labidi-Galy. 2017. Cell Division Machinery and Disease. Cell Division Machinery and Disease 125 152 .
M Cariati, S K Bains, M R Grootendorst, A Suyoi, A M Peters, P Mortimer, P Ellis, M Harries, M Van Hemelrijck & A D Purushotham. (2015) Adjuvant taxanes and the development of breast cancer-related arm lymphoedema. British Journal of Surgery 102:9, pages 1071-1078.
Crossref
Wei-Ling Chang, Chia-Chun Yu, Ching-Shih Chen & Jih-Hwa Guh. (2015) Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – A critical role of Cdk1 in mitotic entry. Biochemical Pharmacology 94:1, pages 12-21.
Crossref
Alexandra S. Zimmer & Patricia S. Steeg. (2014) Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns. Journal of Molecular Medicine 93:1, pages 13-29.
Crossref
Lianlian Song, Shu Sun, Longnan Jin, Lijuan Xue & Yaowen Fu. (2014) The extracts of Holotrichia diomphalia larvae inhibit proliferation and induce apoptosis of cancer cells in vitro and in vivo. Molecular & Cellular Toxicology 10:3, pages 251-259.
Crossref
Shujing Shi, Leilei Tao, Haizhu Song, Longbang Chen & Guichun Huang. (2014) Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice. APMIS 122:5, pages 380-391.
Crossref
J J M A Hendrikx, J S Lagas, E Wagenaar, H Rosing, J H M Schellens, J H Beijnen & A H Schinkel. (2014) Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation. British Journal of Cancer 110:11, pages 2669-2676.
Crossref
Mukesh Verma & Debmalya Barh. 2014. Omics Approaches in Breast Cancer. Omics Approaches in Breast Cancer 393 407 .
Eddy Pasquier, Maria Kavallaris & Nicolas Andre. 2014. Metronomic Chemotherapy. Metronomic Chemotherapy 69 90 .
Antonio Gonzalez-Martin, Laurence Gladieff, Bengt Tholander, Daniel Stroyakovsky, Martin Gore, Giovanni Scambia, Nadezhda Kovalenko, Ana Oaknin, Julian Perez Ronco, Ulrich Freudensprung & Sandro Pignata. (2013) Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer. European Journal of Cancer 49:18, pages 3831-3838.
Crossref
Lei Hu, ShengHua Zhang, RongGuang Shao & YongSu Zhen. (2013) Lidamycin inhibits tumor growth and pulmonary metastasis in murine breast carcinoma and shows synergy with paclitaxel. Chinese Science Bulletin 58:23, pages 2805-2811.
Crossref
Guido Bocci, Antonello Di Paolo & Romano Danesi. (2013) The pharmacological bases of the antiangiogenic activity of paclitaxel. Angiogenesis 16:3, pages 481-492.
Crossref
Mariana S. Nars & Ramon Kaneno. (2012) Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy. International Journal of Cancer 132:11, pages 2471-2478.
Crossref
TOSHIKI SHIMIZU, TAKASHI YOKOI, TAKESHI TAMAKI, KAYOKO KIBATA, NORIKO INAGAKI & SHOSAKU NOMURA. (2013) Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer. Oncology Letters 5:3, pages 761-767.
Crossref
Carla Rohrer Bley, Polina Furmanova, Katrin Orlowski, Nicole Grosse, Angela Broggini-Tenzer, Paul M.J. McSheehy & Martin Pruschy. (2013) Microtubule stabilising agents and ionising radiation: Multiple exploitable mechanisms for combined treatment. European Journal of Cancer 49:1, pages 245-253.
Crossref
Li-Min Luo, Yue Huang, Bing-Xiang Zhao, Xin Zhao, Yu Duan, Ruo Du, Ke-Fu Yu, Ping Song, Yang Zhao, Xuan Zhang & Qiang Zhang. (2013) Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel. Biomaterials 34:4, pages 1102-1114.
Crossref
Jagat R KanwarGanesh Mahidhara & Rupinder K Kanwar. (2012) Novel alginate-enclosed chitosan–calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy. Nanomedicine 7:10, pages 1521-1550.
Crossref
Genevieve M. Weir, Robert S. Liwski & Marc Mansour. (2011) Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines. Cancers 3:3, pages 3114-3142.
Crossref
Jagat R. Kanwar, Ganesh Mahidhara & Rupinder K. Kanwar. (2011) Antiangiogenic therapy using nanotechnological-based delivery system. Drug Discovery Today 16:5-6, pages 188-202.
Crossref
Juyoun Jin, Woo Sirl Lee, Kyeung Min Joo, Kaustabh K. Maiti, Goutam Biswas, Wanil Kim, Kyong-Tai Kim, Se Jeong Lee, Kang-Ho Kim, Do-Hyun Nam & Sung-Kee Chung. (2011) Preparation of blood-brain barrier-permeable paclitaxel-carrier conjugate and its chemotherapeutic activity in the mouse glioblastoma model. MedChemComm 2:4, pages 270.
Crossref
Anil Bagri, Hosein Kouros-Mehr, Kevin G. Leong & Greg D. Plowman. (2010) Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale. Trends in Molecular Medicine 16:3, pages 122-132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.